145 related articles for article (PubMed ID: 32782684)
21. COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling.
Jue C; Min Z; Zhisheng Z; Lin C; Yayun Q; Xuanyi W; Feng J; Haibo W; Youyang S; Tadashi H; Shintaro I; Shiyu G; Yanqing L
J Ethnopharmacol; 2017 Aug; 208():165-173. PubMed ID: 28694103
[TBL] [Abstract][Full Text] [Related]
22. Epithelial cell adhesion molecule and epithelial-mesenchymal transition are associated with vasculogenic mimicry, poor prognosis, and metastasis of triple negative breast cancer.
Wu Q; Wang J; Liu Y; Gong X
Int J Clin Exp Pathol; 2019; 12(5):1678-1689. PubMed ID: 31933986
[TBL] [Abstract][Full Text] [Related]
23. Expression of Dickkopf-1 and Twist2 in Cervical Squamous Cell Carcinoma and Their Correlation with Vasculogenic Mimicry.
Wang B; Zhang H; Wei L; Li Y
J Healthc Eng; 2022; 2022():9288476. PubMed ID: 35340228
[TBL] [Abstract][Full Text] [Related]
24. Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.
Xiao T; Zhong W; Zhao J; Qian B; Liu H; Chen S; Qiao K; Lei Y; Zong S; Wang H; Liang Y; Zhang H; Meng J; Zhou H; Sun T; Liu Y; Yang C
Cell Death Dis; 2018 Sep; 9(9):906. PubMed ID: 30185783
[TBL] [Abstract][Full Text] [Related]
25. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
[TBL] [Abstract][Full Text] [Related]
26. Expression of vimentin and Oct-4 in gallbladder adenocarcinoma and their relationship with vasculogenic mimicry and their clinical significance.
Zhang Y; Xu J; Xu Z; Wang Y; Wu S; Wu L; Song H; Zhou L
Int J Clin Exp Pathol; 2018; 11(7):3618-3627. PubMed ID: 31949742
[TBL] [Abstract][Full Text] [Related]
27. Vasculogenic mimicry and expression of slug and vimentin correlate with metastasis and prognosis in non-small cell lung cancer.
Song H; Ci H; Xu J; Xu Z; Zhang Y; Wang Y; Wu S; Tao Y
Int J Clin Exp Pathol; 2018; 11(5):2749-2758. PubMed ID: 31938392
[No Abstract] [Full Text] [Related]
28. Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.
Yang Z; Sun B; Zhao X; Shao B; An J; Gu Q; Wang Y; Dong X; Zhang Y; Qiu Z
Int J Clin Exp Pathol; 2015; 8(4):4033-43. PubMed ID: 26097591
[TBL] [Abstract][Full Text] [Related]
29. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma.
Sun B; Zhang S; Zhang D; Du J; Guo H; Zhao X; Zhang W; Hao X
Oncol Rep; 2006 Oct; 16(4):693-8. PubMed ID: 16969481
[TBL] [Abstract][Full Text] [Related]
30. The effect of hepatocellular carcinoma-associated fibroblasts on hepatoma vasculogenic mimicry.
She Q; Hu S; Pu X; Guo Q; Mou C; Yang C
Am J Cancer Res; 2020; 10(12):4198-4210. PubMed ID: 33414995
[TBL] [Abstract][Full Text] [Related]
31. [Clinical significance of RYBP expression in primary hepatocellular carcinoma].
Jing X; Cai W; Huang B; Chen H; Chen D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 44(4):399-405. PubMed ID: 31113915
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia induced epithelial-mesenchymal transition and vasculogenic mimicry formation by promoting Bcl-2/Twist1 cooperation.
Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
Exp Mol Pathol; 2015 Oct; 99(2):383-91. PubMed ID: 26318343
[TBL] [Abstract][Full Text] [Related]
33. Protease-activated receptor-1 (PAR1) promotes epithelial-endothelial transition through Twist1 in hepatocellular carcinoma.
Xiao T; Zhang Q; Zong S; Zhong WL; Qin Y; Bi Z; Chen S; Liu HJ; Wei JJ; Zhou BJ; Wang LM; Zhou HG; Liu YR; Sun T; Yang C
J Exp Clin Cancer Res; 2018 Aug; 37(1):185. PubMed ID: 30081924
[TBL] [Abstract][Full Text] [Related]
34. Vasculogenic mimicry in hepatocellular carcinoma contributes to portal vein invasion.
Jue C; Zhifeng W; Zhisheng Z; Lin C; Yayun Q; Feng J; Hao G; Shintaro I; Hisamitsu T; Shiyu G; Yanqing L
Oncotarget; 2016 Nov; 7(47):77987-77997. PubMed ID: 27793002
[TBL] [Abstract][Full Text] [Related]
35. Twist1 promotes astrocytoma development by stimulating vasculogenic mimicry.
Cao W; Xu C; Li X; Yang X
Oncol Lett; 2019 Jul; 18(1):846-855. PubMed ID: 31289562
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D binding protein (VDBP) hijacks twist1 to inhibit vasculogenic mimicry in hepatocellular carcinoma.
Qin LN; Zhang H; Li QQ; Wu T; Cheng SB; Wang KW; Shi Y; Ren HR; Xing XW; Yang C; Sun T
Theranostics; 2024; 14(1):436-450. PubMed ID: 38164156
[No Abstract] [Full Text] [Related]
37. Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma.
Sun T; Sun BC; Zhao XL; Zhao N; Dong XY; Che N; Yao Z; Ma YM; Gu Q; Zong WK; Liu ZY
Hepatology; 2011 Nov; 54(5):1690-706. PubMed ID: 21748764
[TBL] [Abstract][Full Text] [Related]
38. The expressions of CD133, ALDH1, and vasculogenic mimicry in osteosarcoma and their clinical significance.
Bao Z; Cheng Z; Chai D
Int J Clin Exp Pathol; 2018; 11(7):3656-3663. PubMed ID: 31949746
[TBL] [Abstract][Full Text] [Related]
39. Thymidine phosphorylase promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect.
Zhang Q; Qin Y; Zhao J; Tang Y; Hu X; Zhong W; Li M; Zong S; Li M; Tao H; Zhang Z; Chen S; Liu H; Yang L; Zhou H; Liu Y; Sun T; Yang C
Cell Death Dis; 2019 Jan; 10(2):43. PubMed ID: 30674871
[TBL] [Abstract][Full Text] [Related]
40. HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma.
Sun J; Sun B; Sun R; Zhu D; Zhao X; Zhang Y; Dong X; Che N; Li J; Liu F; Zhao N; Wang Y; Zhang D
Sci Rep; 2017 May; 7(1):2229. PubMed ID: 28533522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
